As determined by our isogenic cell‐line model, AXL expression in mesenchymal‐type lung cancer cells, which confers doxorubicin resistance, was upregulated by YAP/TAZ activity primed by the TGFβ‐SMAD axis. The gene discussed is YAP1; the disease is lung carcinoma.